MR/ultrasound fusion-guided biopsy in prostate cancer: what is the evidentiary standard?

Editorial

. 2015 Jan 27;313(4):367-8.

doi: 10.1001/jama.2014.17943.

Affiliations

¹ Department of Radiology, Columbia University College of Physicians and Surgeons, New York, New York2New York Presbyterian Hospital, New York, New York.
² Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill4Associate Editor, JAMA.

Editorial

Lawrence H Schwartz et al. JAMA. 2015.

. 2015 Jan 27;313(4):367-8.

doi: 10.1001/jama.2014.17943.

¹ Department of Radiology, Columbia University College of Physicians and Surgeons, New York, New York2New York Presbyterian Hospital, New York, New York.
² Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill4Associate Editor, JAMA.

No abstract available

Comment on

Comparison of MR/ultrasound fusion-guided biopsy with ultrasound-guided biopsy for the diagnosis of prostate cancer.
Siddiqui MM, Rais-Bahrami S, Turkbey B, George AK, Rothwax J, Shakir N, Okoro C, Raskolnikov D, Parnes HL, Linehan WM, Merino MJ, Simon RM, Choyke PL, Wood BJ, Pinto PA. Siddiqui MM, et al. JAMA. 2015 Jan 27;313(4):390-7. doi: 10.1001/jama.2014.17942. JAMA. 2015. PMID: 25626035 Free PMC article. Clinical Trial.